75 years after Albert Hofmann’s serendipitous discovery of the effects of LSD, the Beckley Foundation and Oxford University Press present a new paperback version of LSD: My Problem Child. This book provides a definitive translation of Albert Hofmann’s autobiography and includes a new collection of essays, ‘Insights/Outlooks.’
Albert Hofmann, who died in 2008 aged 102, first synthesized lysergic acid diethylamide (LSD) in 1938, but the results of animal tests were so unremarkable that the chemical was abandoned. Driven by intuition, he synthesized it again in 1943, and serendipitously noticed its profound effects on himself. Although his work produced other important drugs, including methergine, hydergine and dihydroergotamine, it was LSD that shaped his career.
After his discovery of LSD’s properties, Hofmann spent years researching sacred plants. He succeeded in isolating and synthesizing the active compounds in the Psilocybe mexicana mushroom, which he named psilocybin and psilocin. During the 60s, Hofmann struck up friendships with personalities such as Aldous Huxley, Gordon Wasson, and Timothy Leary. He continued to work at Sandoz until 1971 when he retired as Director of Research for the Department of Natural Products. He subsequently served as a member of the Nobel Prize Committee, and was nominated by Time magazine as one of the most influential figures of the 20th century.
In 2007, Albert Hofmann asked Amanda Feilding if she could publish his Problem Child, and shortly before his death he approved a new and updated translation of his autobiography (first published by McGraw Hill in 1979). It appears here for the first time in print.
On Bicycle Day 2018, Amanda Feilding addressed the LSD75.CH Symposium in Basel. In her speech, ‘From Problem Child to Wonder Child: An Evolving Story..’, she reflects on her memories of Albert Hofmann, her research into psychedelic medicines, and the future she envisions for LSD.
Podcast
Links
Support
BIPRP
Science Talk
Amanda's Talks
One-pager
Music
Amanda Feilding
Events
Highlights
Psilocybin for Depression
Current
Category
Substance/Method
Collaboration
Clinical Application
Policy Focus
Type of publication
Search type